mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.04 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.04 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.04 |